Home » BioNTech » Page 2

BioNTech

Egypt to probe four coronavirus deaths due to alleged lack of oxygen

Egyptian prosecutors opened an investigation into the deaths on Sunday of at least four coronavirus patients at a public Egyptian hospital, after a video of nurses struggling to keep the patients alive was shared widely on social media. The governor of Sharqia province denied allegations by a relative of one of the patients that the deaths were caused by a lack of oxygen at the government-run intensive care unit treating COVID-19 patients. Governor Mamdouh Ghorab said the patients died because they suffered chronic diseases in addition to the virus. The relative, who also filmed the video, offered no immediate evidence to back up their claim that the hospital ran out of oxygen. Egypt, the Arab world’s most populous country with more than 100 million people, is facing a surge in confirmed v...

Jordan detects two coronavirus variant cases – minister

Jordan on Sunday confirmed two cases of a particularly infectious coronavirus variant in a man and his wife who had arrived from Britain. Health Minister Nazir Obeidat said the Jordanian couple travelled to the kingdom on December 19 and were found to be infected with the new strain of the virus after being tested and isolated. The couple were still in quarantine and being monitored by medical experts according to virus protocols, Obeidat said, adding they were both in “excellent health” condition. The new strain of the virus emerged earlier this month in Britain and has already reached several European countries, as well as Japan and Canada. The new strain, which experts fear is more contagious, prompted more than 50 countries to impose travel restrictions on Britain. Jordan was among the...

Germany starts coronavirus vaccines a day early

A 101-year-old woman in an elderly care home became the first person in Germany to be inoculated against coronavirus on Saturday, a day before the official vaccination campaign was scheduled to get under way in both Germany and the EU. Edith Kwoizalla was one of around 40 residents and 10 staff in a care home in the eastern state of Saxony-Anhalt to receive a jab of the Pfizer-BioNTech vaccine, the home’s manager Tobias Krueger told AFP. The Pfizer-BioNTech vaccine became the first to get the go-ahead for use in the West, when Britain gave its approval on December 2. As other nations from the United States to Saudi Arabia to Singapore followed suit, Germany impatiently prodded the EU’s drugs regulator, the European Medicines Agency, to bring forward its decision from December 29. The EMA f...

Official: One million Americans vaccinated against coronavirus

More than a million people have received their first dose of a Covid-19 vaccine in the United States, Centers for Disease Control and Prevention (CDC) director Robert Redfield said Wednesday. “The United States achieved an early but important milestone today — jurisdictions have now reported that more than one million people have received their first dose of Covid-19 vaccine since administration began 10 days ago,” said Redfield. In a call with reporters, Moncef Slaoui, chief advisor of the government’s Operation Warp Speed, said that the objective of immunizing 20 million people this month was “unlikely to be met.” But he said the US was still aiming for 100 million people immunized by the end of the first quarter of 2021, and another 100 million by the second quarter. Three million doses...

First Americans vaccinated as U.S. death toll passes 300,000

An intensive care unit nurse became the first person in the United States to receive the Pfizer/BioNTech COVID-19 vaccine on Monday, calling it a sign that “healing is coming,” as the U.S. coronavirus death toll crossed a staggering 300,000 lives lost. Sandra Lindsay, who has treated some of the sickest COVID-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s COVID-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo. “It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history. “I want to instil...

Canada approves Pfizer-BioNTech coronavirus vaccine

Canadian health officials have authorised the Pfizer-BioNTech COVID-19 vaccine, hailing the development as a “critical milestone” and paving the way for the inoculant to be administered across the country. The authorisation on Wednesday comes a day after the United Kingdom became the first country to begin giving the vaccine to the public. Emergency use authorisation (EUA) is also pending in the United States, with officials saying the first doses could be administered as early as next week. The US Food and Drug Administration is scheduled to consider its EUA on Thursday. Bahrain has also authorised the vaccine for public use. “Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place,” Health Canada, the department responsible fo...

India’s Serum Institute seeks approval for COVID-19 vaccine

The Serum Institute of India, the world’s largest vaccine producer by volume, has sought government approval for emergency-use authorisation of the coronavirus vaccine that it has developed in partnership with the University of Oxford and British drugmaker AstraZeneca. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD,” the company CEO Adar Poonawalla tweeted on Monday. The experimental vaccine can be stored at two to eight degrees Celsius and can be distributed more easily in India, which has the world’s second-highest number of infections at 9.6 million. The company has applied to the Drugs Controller General of India (DCGI), with Poonawalla saying the vaccine will “save countless lives” witho...

Interpol raises the alarm over fake coronavirus vaccines

The International Criminal Police Organisation (INTERPOL) has alerted Nigeria, South Africa, the United Kingdom, the United States, and 190 other countries of threat from organised criminal groups during the upcoming COVID-19 vaccination campaigns, including fake vaccines and the theft of supplies. The alert came as the UK yesterday became the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine for widespread use. The need for a vaccine has become more urgent globally and nationally with Nigeria recording over 67,000 COVID-19 infections and over 1,000 associated fatalities, according to the Nigeria Centre for Disease Control. The World Health Organisation (WHO) has so far identified 49 “candidate vaccines” at the stage of clinical trials in humans. Hopes are high ...

EU criticises ‘hasty’ UK approval of coronavirus vaccine

The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot. The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic. The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials. In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving COVID...

Coronavirus vaccine breakthrough raises hopes of rapid global rollout

A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...